PDF herunterladen
Neurochirurgie Scan 2016; 04(01): 63-81
DOI: 10.1055/s-0041-107748
Fortbildung
Schmerz
© Georg Thieme Verlag KG Stuttgart · New York

Neuromodulation zur Schmerztherapie – was ist sinnvoll?

Volker Tronnier
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
08. Februar 2016 (online)

Auch verfügbar auf
    Lizenzen und Reprints

Zusammenfassung

In der Schmerztherapie haben Neuromodulationsverfahren die früher durchgeführten läsionellen Methoden bis auf wenige Ausnahmen abgelöst. Dennoch handelt es sich bei diesen Verfahren um invasive Techniken mit therapiespezifischen Risiken und Komplikationen, sodass vor dem Einsatz von Neuromodulationsverfahren weniger invasive physikalische, psychologische, medikamentöse und interventionelle Techniken zum Einsatz gekommen sein müssen. Da es sich zudem um eine kostenintensive Therapie handelt, muss die Indikation genau geprüft werden, die Patientenselektion strikt sein und letztlich auch die Effektivität der Therapie im Langzeitverlauf gesichert sein. Der vorliegende Beitrag gibt einen Überblick über die aktuellen Neuromodulationsverfahren, ihre Indikationen und die publizierten Ergebnisse.

 

  • Literatur

  • 1 Melzack R, Wall PD. Pain mechanisms: a new theory. Science 1965; 150: 971-979
    CrossrefPubMedGoogle Scholar
  • 2 Sommer C, Birklein F. Das komplexe regionale Schmerzsyndrom. Neurochirurgie Scan 2015; 1: 47-61
    Artikel in Thieme ConnectGoogle Scholar
  • 3 Hassenbusch SJ, Stanton-Hicks M, Schoppa M et al. Long-term results of peripheral nerve stimulation for reflex sympathetic dystrophy. J Neurosurg 1996; 84: 415-423
    CrossrefGoogle Scholar
  • 4 Buschmann D, Oppel F. Periphere Nervenstimulation. Schmerz 1999; 13: 113-120
    CrossrefGoogle Scholar
  • 5 Eisenberg E, Waisbrod H, Gerbershagen HU. Long-term peripheral nerve stimulation for painful nerve injuries. Clin J Pain 2004; 20: 143-146
    CrossrefGoogle Scholar
  • 6 Van Calenbergh F, Gybels J, Van Laere K et al. Long term clinical outcome of peripheral nerve stimulation in patients with chronic peripheral neuropathic pain. Surg Neurol 2009; 72: 330-335
    CrossrefGoogle Scholar
  • 7 Weiner RL, Reed KL. Peripheral neurostimulation for control of intractable occipital neuralgia. Neuromodulation 1999; 2: 217-221
    CrossrefGoogle Scholar
  • 8 May A. Cluster headache: pathogenesis, diagnosis, and management. Lancet 2005; 366: 843-855
    CrossrefGoogle Scholar
  • 9 Saper JR, Dodick DW, Silberstein SD et al. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia 2011; 31: 271-285
    CrossrefGoogle Scholar
  • 10 Silberstein SD, Dodick DW, Saper J et al. Safety and efficacy of peripheral nerve stimulation of the occipital nerves for the management of chronic migraine: results from a randomized, multicenter, doubleblinded, controlled study. Cephalalgia 2012; 32: 1165-1179
    CrossrefGoogle Scholar
  • 11 Verrills P, Rose R, Mitchell B et al. Peripheral nerve field stimulation for chronic headache: 60 cases and long-term follow-up. Neuromodulation 2013; 17: 54-59
    Google Scholar
  • 12 Magis D, Allena M, Bolla M et al. Occipital nerve stimulation for drug-resistant chronic cluster headache: a prospective pilot study. Lancet Neurol 2007; 6: 314-321
    CrossrefPubMedGoogle Scholar
  • 13 Magis D, Schoenen J. Advances and challenges in neurostimulation for headaches. Lancet Neurol 2012; 11: 708-719
    CrossrefGoogle Scholar
  • 14 Burns B, Watkins L, Goadsby PJ. Treatment of intractable chronic cluster headache by occipital nerve stimulation in 14 patients. Neurology 2009; 72: 341-345
    CrossrefGoogle Scholar
  • 15 Fontaine D, Christophe Sol J, Raoul S et al. Treatment of refractory chronic cluster headache by chronic occipital nerve stimulation. Cephalalgia 2011; 31: 1101-1105
    CrossrefGoogle Scholar
  • 16 Burns B, Watkins L, Goadsby PJ. Treatment of hemicrania continua by occipital nerve stimulation with a bion device: long-term follow-up of a crossover study. Lancet Neurol 2008; 7: 1001-1012
    CrossrefGoogle Scholar
  • 17 Lambru G, Shanahan P, Watkins L et al. Occipital nerve stimulation in the treatment of medically intractable SUNCT and SUNA. Pain Physician 2014; 17: 29-41
    Google Scholar
  • 18 Jürgens T, Paulus W, Tronnier V et al. Einsatz neuromodulierender Verfahren bei primären Kopfschmerzen. Therapieempfehlungen der Deutschen Migräne- und Kopfschmerzgesellschaft. Nervenheilkunde 2011; 1–2: 47-58
    Google Scholar
  • 19 Marteletti P, Jensen RH, Antal A et al. Neuromodulation of chronic headaches: position statement from the European Headache Federation. J Headache Pain 2013; 14: 86
    CrossrefGoogle Scholar
  • 20 Brewer AC, Trentman TL, Ivancic MG et al. Long-term outcome in occipital nerve stimulation patients with medically intractable primary headache disorders. Neuromodulation 2013; 16: 557-564
    CrossrefGoogle Scholar
  • 21 Sharan A, Huh B, Narouze S et al. Analysis of adverse events in the management of chronic migraine by peripheral nerve stimulation. Neuromodulation 2015; 18: 305-312
    CrossrefGoogle Scholar
  • 22 Ansarinia M, Rezai A, Tepper SJ et al. Electrical stimulation of sphenopalatine ganglion for acute treatment of cluster headaches. Headache 2010; 50: 1164-1174
    CrossrefGoogle Scholar
  • 23 Tepper SJ, Rezai A, Narouze S et al. Acute treatment of intractable migraine with sphenopalatine ganglion electrical stimulation. Headache 2009; 49: 983-989
    CrossrefGoogle Scholar
  • 24 Schoenen J, Jensen RH, Lantéri-Minet M et al. Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: a randomized, sham-controlled study. Cephalalgia 2013; 33: 816-830
    CrossrefGoogle Scholar
  • 25 Lenaerts ME, Oommen KJ, Couch JR et al. Can vagus nerve stimulation help migraine?. Cephalalgia 2008; 28: 392-395
    CrossrefGoogle Scholar
  • 26 Mauskop A. Vagus nerve stimulation relieves chronic refractory migraine and cluster headaches. Cephalalgia 2005; 25: 82-86
    CrossrefGoogle Scholar
  • 27 Cairns KD, McRoberts WP, Deer T. Peripheral nerve stimulation for the treatment of truncal pain. Prog Neurol Surg 2011; 24: 58-69
    Google Scholar
  • 28 Paicius RM, Bernstein CA, Lempert-Cohen C. Peripheral nerve field stimulation in chronic abdominal pain. Pain Physician 2006; 9: 261-266
    Google Scholar
  • 29 Matsuo H, Uchida K, Nakajima H et al. Early transcutaneous electrical nerve stimulation reduces hyperalgesia and decreases activation of spinal glial cells in mice with neuropathic pain. Pain 2014; 155: 1888-1901
    CrossrefGoogle Scholar
  • 30 Hamm-Faber TE, Aukes H, van Gorp EJ et al. Subcutaneous Stimulation as an Additional Therapy to Spinal Cord Stimulation for the Treatment of Low Back Pain and Leg Pain in Failed Back Surgery Syndrome: Four-Year Follow-Up. Neuromodulation 06.05.2015; [Epub ahead of print] DOI: 10.1111/ner.12309.
    Google Scholar
  • 31 Reverberi C, Dario A, Barolat G. Spinal cord stimulation (SCS) in conjunction with peripheral nerve field stimulation (PNfS) for the treatment of complex pain in failed back surgery syndrome (FBSS). Neuromodulation 2013; 16: 78-82
    CrossrefGoogle Scholar
  • 32 Kloimstein H, Likar R, Kern M et al. Peripheral nerve field stimulation (PNFS) in chronic low back pain: a prospective multicenter study. Neuromodulation 2014; 17: 180-187
    CrossrefGoogle Scholar
  • 33 McRoberts WP, Wolkowitz R, Meyer DJ et al. Peripheral nerve field stimulation for the management of localized chronic intractable back pain: results from a randomized controlled study. Neuromodulation 2013; 16: 565-574
    CrossrefGoogle Scholar
  • 34 Shealy CN, Mortimer JT, Reswick JB. Electrical inhibition of pain by stimulation of the dorsal columns: preliminary clinical report. Anesth Analg 1967; 46: 489-491
    Google Scholar
  • 35 Hosobuchi Y, Adams JE, Weinstein PR. Preliminary percutaneous dorsal column stimulation prior to permanent implantation. Technical note. J Neurosurg 1972; 37: 242-245
    CrossrefGoogle Scholar
  • 36 North RB, Fischell TA, Long DM. Chronic stimulation via percutaneously inserted epidural electrodes. Neurosurgery 1977; 1: 215-218
    Google Scholar
  • 37 Urban BJ, Nashold BS. Percutaneous epidural stimulation of the spinal cord for relief of pain. J Neurosurg 1978; 48: 323-328
    CrossrefGoogle Scholar
  • 38 Shatin D, Mullett K, Hults G. Totally implantable spinal cord stimulation for chronic pain: design and efficacy. Pacing Clin Electrophysiol 1986; 9: 577-583
    CrossrefGoogle Scholar
  • 39 North RB, Kidd DH, Olin JC et al. Spinal cord stimulation electrode design: prospective, randomized, controlled trial comparing percutaneous and laminectomy electrodes – part I: technical outcomes. Neurosurgery 2002; 51: 381-390
    Google Scholar
  • 40 Richter E, Abramova M, Alò K. Low back paresthesia coverage with lateral programming of five-column paddle leads: technical report. J Neurosurg Rev 2011; 1 (Suppl. 01) 64-68
    Google Scholar
  • 41 Holsheimer J, Wesselink WA. Effect of anode-cathode configuration on paresthesia coverage in spinal cord stimulation. Neurosurgery 1997; 41: 654-660
    Google Scholar
  • 42 Lam CK, Rosenow JM. Patient perspectives on the efficacy and ergonomics of rechargeable spinal cord stimulators. Neuromodulation 2010; 13: 218-223
    CrossrefGoogle Scholar
  • 43 Coffey RJ, Kalin R, Olsen JM. Magnetic resonance imaging conditionally safe neurostimulation leads: investigation of the maximum safe lead tip temperature. Neurosurgery 2014; 74: 215-224
    CrossrefGoogle Scholar
  • 44 De Andres J, Valia JC, Cerda-Olmedo G et al. Magnetic resonance imaging in patients with spinal neurostimulation systems. Anesthesiology 2007; 106: 779-786
    CrossrefGoogle Scholar
  • 45 Tronnier VM, Staubert A, Hähnel S et al. Magnetic resonance imaging with implanted neurostimulators: an in-vitro and in-vivo study. Neurosurgery 1999; 44: 118-125
    CrossrefGoogle Scholar
  • 46 Sparkes E, Raphael JH, Duarte RV et al. A systematic literature review of psychological characteristics as determinants of outcome for spinal cord stimulation therapy. Pain 2010; 150: 284-289
    CrossrefGoogle Scholar
  • 47 Turner JA, Hollingworth W, Comstock BA et al. Spinal cord stimulation for failed back surgery syndrome: outcomes in a workersʼ compensation setting. Pain 2010; 148: 14-25
    CrossrefGoogle Scholar
  • 48 Campbell JN, Raja SN, Meyer RA et al. Myelinated afferents signal the hyperalgesia associated with nerve injury. Pain 1988; 32: 89-94
    CrossrefGoogle Scholar
  • 49 Woolf CJ, Doubell TP. The pathophysiology of chronic pain – increased sensitivity to low threshold Aβ-fiber inputs. Curr Opin Neurobiol 1994; 14: 525-534
    Google Scholar
  • 50 Meyerson BA, Ren B, Herregodts P et al. Spinal cord stimulation in animal models of mononeuropathy: Effects on the withdrawal response and the flexor reflex. Pain 1995; 61: 229-243
    CrossrefGoogle Scholar
  • 51 Yakhnitsa V, Linderoth B, Meyerson BA. Spinal cord stimulation attenuates dorsal horn neuronal hyperexcitability in a rat model of mononeuropathy. Pain 1999; 79: 223-233
    CrossrefGoogle Scholar
  • 52 Linderoth B, Foreman RD. Physiology of spinal cord stimulation: Review and update. Neuromodulation 1999; 2: 150-164
    CrossrefGoogle Scholar
  • 53 Linderoth B, Gazelius B, Franck J et al. Dorsal column stimulation induces release of serotonin and substance P in the cat dorsal horn. Neurosurgery 1992; 31: 289-297
    CrossrefGoogle Scholar
  • 54 Meyerson BA, Brodin E, Linderoth B. Possible neurohumoral mechanisms in CNS stimulation for pain suppression. Appl Neurophysiol 1985; 48: 175-180
    Google Scholar
  • 55 Linderoth B, Stiller CO, Gunasekera L et al. Gamma-aminobutyric acid is released in the dorsal horn by electrical spinal cord stimulation: an in vivo microdialysis study in the rat. Neurosurgery 1994; 34: 484-489
    CrossrefGoogle Scholar
  • 56 Stiller CO, Cui J-G, O’Connor WT et al. Release of GABA in the dorsal horn and suppression of tactile allodynia by spinal cord stimulation in mononeuropathic rats. Neurosurgery 1996; 39: 367-375
    CrossrefGoogle Scholar
  • 57 Simpson RD, Robertson CS, Goodman JC. Glycine: a potential mediator of electrically induced pain modification. Biomed Lett 1993; 48: 193-207
    Google Scholar
  • 58 Kanqrqa I, Jiang MC, Randic M. Actions of (−)-baclofen on rat dorsal horn neurons. Brain Res 1991; 562: 265-275
    CrossrefGoogle Scholar
  • 59 Cui JG, Sollevi A, Linderoth B et al. Effect of low-adenosine receptor activation suppresses tactile hypersensitivity and potentiates effect of spinal cord in mononeuropathic rats. Neurosci Lett 1997; 223: 173-176
    CrossrefGoogle Scholar
  • 60 Barchini J, Tchachagian S, Shamaa F et al. Spinal segmental and supraspinal mechanisms underlying the pain-relieving effects of spinal cord stimulation: an experimental study in a rat model of neuropathy. Neuroscience 2012; 215: 196-208
    CrossrefGoogle Scholar
  • 61 Rasche D, Siebert S, Stippich C et al. Epidurale Rückenmarkstimulation bei Postnukleotomiesyndrom. Pilotstudie zur Therapieevaluation mit der funktionellen Magnetresonanztomographie (f-MRT). Schmerz 2005; 19: 497-505
    CrossrefGoogle Scholar
  • 62 Kemler MA, de Vet HC, Barendse GA et al. Effect of spinal cord stimulation for chronic complex regional pain syndrome Type I: five-year final follow-up of patients in a randomized controlled trial. J Neurosurg 2008; 108: 292-298
    CrossrefGoogle Scholar
  • 63 Kumar K, Taylor RS, Jacques L et al. The effects of spinal cord stimulation in neuropathic pain are sustained: a 24-month follow-up of the prospective randomized controlled multicenter trial of the effectiveness of spinal cord stimulation. Neurosurgery 2008; 63: 762-770
    CrossrefPubMedGoogle Scholar
  • 64 North RB, Kidd DH, Farrokhi F et al. Spinal cord stimulation versus repeated lumbosacral spine surgery for chronic pain: a randomized, controlled trial. Neurosurgery 2005; 56: 98-106
    CrossrefGoogle Scholar
  • 65 North RB, Kumar K, Wallace MS et al. Spinal cord stimulation versus re-operation in patients with failed back surgery syndrome: an international multicenter randomized controlled trial (EVIDENCE study). Neuromodulation 2011; 14: 330-335
    CrossrefGoogle Scholar
  • 66 Slangen R, Schaper NC, Faber CG et al. Spinal cord stimulation and pain relief in painful diabetic peripheral neuropathy: a prospective two-center randomized controlled trial. Diabetes Care 2014; 37: 3016-3024
    CrossrefGoogle Scholar
  • 67 de Vos CC, Meier K, Zaalberg PB et al. Spinal cord stimulation in patients with painful diabetic neuropathy: a multicentre randomized clinical trial. Pain 2014; 155: 2426-2431
    CrossrefGoogle Scholar
  • 68 NICE technology appraisal guidance 159. Spinal cord stimulation for chronic pain of neuropathic and ischaemic origin. 2011 http://www.nice.org.uk/TA159
    Google Scholar
  • 69 Tronnier V, Baron R, Birklein F et al. Epidurale Rückenmarkstimulation zur Therapie chronischer Schmerzen. Schmerz 2011; 25: 484-492
    CrossrefGoogle Scholar
  • 70 Kumar K, Caraway DL, Rizvi S et al. Current challenges in spinal cord stimulation. Neuromodulation 2014; 17 (Suppl. 01) 22-35
    Google Scholar
  • 71 Kapural L, Cywinski JB, Sparks DA. Spinal cord stimulation for visceral pain from chronic pancreatitis. Neuromodulation 2011; 14: 423-426
    CrossrefPubMedGoogle Scholar
  • 72 Lanza GA, Barone L, Di Monaco A. Effect of spinal cord stimulation in patients with refractory angina: evidence from observational studies. Neuromodulation 2012; 15: 542-549
    CrossrefGoogle Scholar
  • 73 Ubbink DT, Vermeulen H. Spinal cord stimulation for non-reconstructable chronic critical leg ischaemia. Cochrane Database Syst Rev 28.02.2013; 2: CD004001
    Google Scholar
  • 74 Mailis A, Taenzer P. Evidence-based guidelines for neuropathic pain interventional treatments: spinal cord stimulation, intravenous infusions, epidural injections and nerve blocks. Pain Res Manage 2012; 17: 150-158
    Google Scholar
  • 75 Airaksinen O, Hildebrandt J, Mannion AF et al. European guidelines for the management of chronic non-specific low back pain. Eur Spine J 2006; 15 (Suppl. 02) 192-300
    CrossrefGoogle Scholar
  • 76 Manchikanti L, Boswell MV, Sing V et al. Comprehensive evidence-based guidelines for interventional techniques for the management of chronic spinal pain. Pain Physician 2009; 12: 699-802
    Google Scholar
  • 77 Hegmann KT. Low back disorders. Hegmann KT, ed. Occupational medicine practice guidelines. Evaluation and management of common health problems and functional recovery in workers. 3rd ed. Elk Grove Village (IL): American College of Occupational and Environmental Medicine (ACOEM); 2011: 333-796
    Google Scholar
  • 78 Chou R, Loeser JD, Owens DK et al. Interventional therapies, surgeries, and interdisciplinary rehabilitation for low back pain. Spine 2009; 34: 1066-1077
    CrossrefGoogle Scholar
  • 79 Montalescot G, Sechtem U, Achenbach S et al. 2013 ESC guidelines on the management of stable coronary disease. Eur Heart J 2013; 34: 2949-3003
    CrossrefGoogle Scholar
  • 80 Schu S, Slotty PJ, Bara G et al. A prospective, randomized, double blind, placebo-controlled study to examine the effectiveness of burst spinal cord stimulation patterns for the treatment of failed back surgery syndrome. Neuromodulation 2014; 14: 443-450
    Google Scholar
  • 81 De Ridder D, Plazier M, Kamerling N et al. Burst spinal cord stimulation for limb and back pain. World Neurosurg 2013; 80: 642-649
    CrossrefGoogle Scholar
  • 82 De Ridder D, Lenders MW, De Vos CC et al. A 2-center comparative study on tonic versus burst spinal cord stimulation: amount of responders and amount of pain suppression. Clin J Pain 2015; 31: 433-437
    CrossrefGoogle Scholar
  • 83 Tiede J, Brown L, Gekht G et al. Novel spinal cord stimulation parameters in patients with predominant back pain. Neuromodulation 2013; 16: 370-375
    CrossrefGoogle Scholar
  • 84 Kapural L, Yu C, Doust MW et al. Novel 10-kHz high-frequency therapy (HF10 Therapy) is superior to traditional low-frequency spinal cord stimulation for the treatment of chronic back and leg pain. The SENZA-RCT randomized controlled trial. Anesthesiology 2015; 123: 851-860
    CrossrefGoogle Scholar
  • 85 Van Buyten JP, Al Kaisy A, Smet I et al. High-frequency spinal cord stimulation for the treatment of chronic back pain patients: results of a prospective multicenter European clinical study. Neuromodulation 2013; 16: 59-66
    CrossrefGoogle Scholar
  • 86 Krames ES. The role of the dorsal root ganglion in the development of neuropathic pain. Pain Med 2014; 15: 1669-1685
    CrossrefGoogle Scholar
  • 87 Liem L, Russo M, Huygen FJ et al. A multicenter, prospective trial to assess the safety and performance of the spinal modulation dorsal root ganglion neurostimulator system in the treatment of chronic pain. Neuromodulation 2013; 16: 471-482
    CrossrefGoogle Scholar
  • 88 Liem L, Russo M, Huygen FJ et al. One-year outcomes of spinal cord stimulation of the dorsal root ganglion in the treatment of chronic neuropathic pain. Neuromodulation 2015; 18: 41-49
    CrossrefGoogle Scholar
  • 89 Huygen FJPM, Baranidharan G, Simpson K et al. An upper limb neuropathic pain cohort treated with stimulation of dorsal root ganglia (DRG): pooled data from four prospective European studies. Abstract. Las Vegas: 18th Annual Meeting of the North American Neuromodulation Society, December 11–14, 2014
    Google Scholar
  • 90 Schu S, Gulve A, Eldabe S et al. Spinal cord stimulation of the dorsal root ganglion for groin pain – a retrospective review. Pain Pract 2015; 15: 293-299
    CrossrefGoogle Scholar
  • 91 Tsubokawa T, Katayama Y, Yamamoto T. Chronic motor cortex stimulation for the treatment of central pain. Acta Neurochir Suppl Wien 1991; 52: 137-139
    Google Scholar
  • 92 Monsalve GA. Motor cortex stimulation for facial chronic neuropathic pain: A review of the literature. Surg Neurol Int 2012; 3 (Suppl. 04) 290-311
    CrossrefGoogle Scholar
  • 93 Nguyen JP, Nizard K, Keravel Y et al. Invasive brain stimulation for the treatment of neuropathic pain. Nat. Rev. Neurol 2011; 7: 699-709
    CrossrefGoogle Scholar
  • 94 García-Larrea L, Peyron R, Mertens P et al. Electrical stimulation of motor cortex for pain control: a combined PET-scan and electrophysiological study. Pain 1999; 83: 259-273
    CrossrefGoogle Scholar
  • 95 Peyron R, Laurent B, García-Larrea L. Functional imaging of brain responses to pain. A review and meta-analysis. Neurophysiol Clin 2000; 30: 263-288
    CrossrefGoogle Scholar
  • 96 Rasche D, Ruppolt M, Stippich C et al. Motor cortex stimulation for long-term relief of chronic neuropathic pain: a 10 year experience. Pain 2006; 121: 43-52
    CrossrefGoogle Scholar
  • 97 Velasco F, Carrillo-Ruiz JD, Castro G et al. Motor cortex electrical stimulation applied to patients with complex regional pain syndrome. Pain 2009; 147: 91-98
    CrossrefGoogle Scholar
  • 98 Fontaine D, Hamani C, Lozano A. Efficacy and safety of motor cortex stimulation for chronic neuropathic pain: critical review of the literature. J Neurosurg 2009; 110: 251-256
    CrossrefGoogle Scholar
  • 99 Boccard SG, Pereira EA, Moir L et al. Long-term outcomes of deep brain stimulation for neuropathic pain. Neurosurgery 2013; 72: 221-230
    CrossrefGoogle Scholar
  • 100 Boccard SG, Fitzgerald JJ, Pereira EA et al. Targeting the affective component of chronic pain: a case series of deep brain stimulation of the anterior cingulate cortex. Neurosurgery 2014; 74: 628-635
    CrossrefGoogle Scholar
  • 101 Rasche D, Rinaldi PC, Young RF et al. Deep brain stimulation for the treatment of various chronic pain syndromes. Neurosurg Focus 2006; 21: E8
    Google Scholar
  • 102 Keifer Jr OP, Riley JP, Boulis NM. Deep brain stimulation for chronic pain: intracranial targets, clinical outcomes, and trial design considerations. Neurosurg Clin N Am 2014; 25: 671-692
    CrossrefGoogle Scholar
  • 103 Bazin C, Poirier AL, Dupoiron D. Influence of pH and temperature on ziconotide stability in intrathecal analgesic admixtures in implantable pumps and syringes. Int J Pharm 2015; 487: 285-291
    CrossrefGoogle Scholar
  • 104 Dupoiron D, Richard H, Chabert-Desnot V et al. In vitro stability of low-concentration ziconotide alone or in admixtures in intrathecal pumps. Neuromodulation 2014; 17: 472-482
    CrossrefGoogle Scholar
  • 105 Shields D, Montenegro R, Ragusa M. Chemical stability of admixtures combining ziconotide with Morphine or Hydromorphone during simulated intrathecal administration. Neuromodulation 2005; 8: 257-263
    CrossrefGoogle Scholar
  • 106 Shields D, Montenegro R, Aclan J. Chemical stability of an admixture combining ziconotide and bupivacaine during simulated intrathecal administration. Neuromodulation 2007; 10 (Suppl. 01) 1-5
    Google Scholar
  • 107 Shields D, Montenegro R. Chemical stability of ziconotide-clonidine hydrochloride admixtures with and without morphine sulfate during simulated intrathecal administration. Neuromodulation 2007; 10 (Suppl. 01) 6-11
    Google Scholar
  • 108 Shields D, Montenegro R, Aclan J. Chemical stability of admixtures combining ziconotide with baclofen during simulated intrathecal administration. Neuromodulation 2007; 10 (Suppl. 01) 12-17
    Google Scholar
  • 109 Smith TJ, Staats PS, Deer T et al. Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: Impact on pain, drug-related toxicity and survival. J Clin Oncol 2002; 20: 4040-4049
    CrossrefGoogle Scholar
  • 110 Staats PS, Yearwood T, Charapata SG et al. Intrathecal ziconotide in the treatment of refractory pain in patients with cancer or AIDS. JAMA 2004; 291: 63-70
    CrossrefGoogle Scholar
  • 111 Alicino I, Giglio M, Manca F et al. Intrathecal combination of ziconotide and morphine for refractory cancer pain: a rapidly acting and effective choice. Pain 2012; 153: 245-249
    CrossrefGoogle Scholar
  • 112 Ballantyne JC, Carwood CM. Comparative efficacy of epidural, subarachnoid, and intracerebroventricular opioids in patients with pain due to cancer. Cochrane Database Syst Rev 25.01.2005; CD005178
    Google Scholar
  • 113 Rauck RL, Wallace MS, Leong MS et al. A randomized, double-blind, placebo-controlled study of intrathecal ziconotide in adults with severe chronic pain. J Pain Symptom Manage 2006; 31: 393-406
    CrossrefGoogle Scholar
  • 114 Wallace MS, Charapata SG, Fisher R et al. Intrathecal ziconotide in the treatment of chronic nonmalignant pain: a randomized, double-blind, placebo-controlled clinical trial. Neuromodulation 2006; 9: 75-86
    CrossrefGoogle Scholar
  • 115 Hassenbusch SJ, Stanton-Hicks M, Covington E et al. Long-term intraspinal infusions of opioids in the treatment of neuropathic pain. J Pain Symptom Manage 1995; 10: 527-543
    CrossrefGoogle Scholar
  • 116 Krames ES, Lanning RM. Intrathecal infusional analgesia for nonmalignant pain: analgesic efficacy of intrathecal opioid with or without bupivacaine. J Pain Symptom Manage 1993; 8: 539-548
    CrossrefGoogle Scholar
  • 117 Winkelmüller M, Winkelmüller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 1996; 85: 458-467
    CrossrefGoogle Scholar
  • 118 Deer T, Prager J, Levy R et al. Polyanalgesic Consensus Conference 2012: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel. Neuromodulation 2012; 15: 436-466
    CrossrefGoogle Scholar
  • 119 Tronnier V, Hofacker W, Ilias W et al. Empfehlungen zum klinischen Einsatz von Ziconotid zur intrathekalen Therapie chronischer Schmerzen. MMW Fortschr Med 2010; 152 (Suppl. 03) 106-109
    Google Scholar
  • 120 Mohammed SI, Eldabe S, Simpson KH et al. Bolus intrathecal injection of ziconotide (Prialt®) to evaluate the option of continuous administration via an implanted intrathecal drug delivery (ITDD) system: a pilot study. Neuromodulation 2013; 16: 576-581
    CrossrefGoogle Scholar
  • 121 Webster LR, Fakata KL, Charapata S et al. Open-label, multicenter study of combined intrathecal morphine and ziconotide: addition of morphine in patients receiving ziconotide for severe chronic pain. Pain Med 2008; 9: 282-290
    CrossrefGoogle Scholar
  • 122 Obafemi A, Roth B. Prolonged delirium with psychotic features from omega conotoxin toxicity. Pain Med 2013; 14: 447-448
    CrossrefGoogle Scholar
  • 123 Wallace MS, Rauck RL, Deer T. Ziconotide combination intrathecal therapy: rationale and evidence. Clin J Pain 2010; 26: 635-644
    CrossrefGoogle Scholar
  • 124 Deer TR, Levy R, Prager J et al. Polyanalgesic Consensus Conference 2012: recommendations to reduce morbidity and mortality in intrathecal drug delivery in the treatment of chronic pain. Neuromodulation 2012; 15: 467-482
    CrossrefGoogle Scholar
  • 125 Webster LR. The relationship between the mechanism of action and safety profiles of intrathecal morphine and ziconotide: A review of the literature. Pain Med 2015; 16: 1265-1277
    CrossrefGoogle Scholar